Global Non-invasive Prenatal Paternity Testing(NIPPT) Market Growth (Status and Outlook) 2024-2030

Global Non-invasive Prenatal Paternity Testing(NIPPT) Market Growth (Status and Outlook) 2024-2030

Non-invasive Prenatal Paternity Testing (NIPPT) is a method used to establish paternity before a child is born without the need for invasive procedures, such as amniocentesis or chorionic villus sampling. It relies on analyzing cell-free fetal DNA present in the mother's blood to determine the biological relationship between the alleged father and the unborn child.

The global Non-invasive Prenatal Paternity Testing(NIPPT) market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.

LPI (LP Information)' newest research report, the “Non-invasive Prenatal Paternity Testing(NIPPT) Industry Forecast” looks at past sales and reviews total world Non-invasive Prenatal Paternity Testing(NIPPT) sales in 2022, providing a comprehensive analysis by region and market sector of projected Non-invasive Prenatal Paternity Testing(NIPPT) sales for 2023 through 2029. With Non-invasive Prenatal Paternity Testing(NIPPT) sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Non-invasive Prenatal Paternity Testing(NIPPT) industry.

This Insight Report provides a comprehensive analysis of the global Non-invasive Prenatal Paternity Testing(NIPPT) landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Non-invasive Prenatal Paternity Testing(NIPPT) portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Non-invasive Prenatal Paternity Testing(NIPPT) market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Non-invasive Prenatal Paternity Testing(NIPPT) and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Non-invasive Prenatal Paternity Testing(NIPPT).

United States market for Non-invasive Prenatal Paternity Testing(NIPPT) is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

China market for Non-invasive Prenatal Paternity Testing(NIPPT) is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Europe market for Non-invasive Prenatal Paternity Testing(NIPPT) is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Global key Non-invasive Prenatal Paternity Testing(NIPPT) players cover Express Diagnostic Center (EDC), AlphaBiolabs, Natera, Illumina, BGI Genomics, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2023.

This report presents a comprehensive overview, market shares, and growth opportunities of Non-invasive Prenatal Paternity Testing(NIPPT) market by product type, application, key players and key regions and countries.

Segmentation by Type:
Service
Reagents

Segmentation by Application:
Non-legal Paternity Test
Legal Paternity Test

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

Segmentation by Type:
Service
Reagents

Segmentation by Application:
Non-legal Paternity Test
Legal Paternity Test

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Express Diagnostic Center (EDC)
AlphaBiolabs
Natera
Illumina
BGI Genomics
Roche company
LabCorp
DDC
International Biosciences
Axis DNA Labs
AffinityDNA
Ultrasound Plus
PrenatalGeneticslab
Acecgt Group
EasyDNA
DNAQ
Choice DNA
DNA Forensics Laboratory
Brooklyn DNA Testing
SmarTest Labs
Fastest Labs
Validity Genetics
Suspire LLC
Carlson Company
PTC Laboratories
My Forever DNA
Dynacare
Vgenes Inc

Please note: The report will take approximately 2 business days to prepare and deliver.